Skip to search.
 FTSE 100 Down 1.99%

More On UCBJY

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

UCB S.A. (UCBJY)

-Other OTC
37.73 Down 0.34(0.89%) 31 Aug 19:33
Add to Portfolio
Prev Close:38.07
Open:37.88
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:0.743955
Next Earnings Date:N/A
Day's Range:37.73 - 37.73
52wk Range:34.10 - 47.85
Volume:208
Avg Vol (3m):445
Market Cap:14.24b
P/E (ttm):37.75
EPS (ttm):1.00
Div & Yield:0.59 (1.55%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for UCBJY at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.45
Ex-Dividend Date:30-Apr-15

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

UCB S.A., a biopharmaceutical company, focuses on the discovery and development of medicines and solutions for people living with severe diseases of the immune system or of the central nervous system in Belgium and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback